About Acasti Pharma (CVE:ACST)
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. The company's lead product candidate is CaPre, an omega-3 phospholipid for the treatment of hypertriglyceridemia. Acasti Pharma Inc. was incorporated in 2002 and is based in Laval, Canada.
Industry, Sector and Symbol
Trailing P/E Ratio-1.29
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-107.02%
Return on Assets-85.51%
Acasti Pharma (CVE:ACST) Frequently Asked Questions
What is Acasti Pharma's stock symbol?
Acasti Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST."
Who are some of Acasti Pharma's key competitors?
Some companies that are related to Acasti Pharma include Pan Orient Energy (POE), Africa Energy (AFE), Atacama Pacific Gold (ATM), Strategic Oil & Gas (SOG), C-Com Satellite Systems (CMI), Ikkuma Resources (IKM), CRH Medical (CRM), Aveda Transportation and Energy Svcs (AVE), Avante Logixx (XX), Energold Drilling (EGD), Abcourt Mines (ABI), Crown Point Energy (CWV), Oceanic Iron Ore (FEO), Champion Bear Resources (CBA), Alderon Iron Ore (ADV), New Zealand Energy (NZ), Hyperion Exploration (HYX) and North American Tungsten (NTC).
Who are Acasti Pharma's key executives?
Acasti Pharma's management team includes the folowing people:
- Roderick Noel Carter, Executive Chairman of the Board
- Janelle D'Alvise, President, Chief Executive Officer, Director
- Linda Parinella O'Keefe, Chief Financial Officer
- Pierre Lemieux Ph.D., Chief Operating Officer
- Laurent Harvey, Vice President- Clinical and Non-Clinical Affairs
- Jean-Daniel Belanger, Secretary, Director- Corporate Affairs
- Jean-Marie Canan, Director (Age 60)
How do I buy Acasti Pharma stock?
Shares of Acasti Pharma and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Acasti Pharma's stock price today?
One share of Acasti Pharma stock can currently be purchased for approximately C$1.29.
How big of a company is Acasti Pharma?
Acasti Pharma has a market capitalization of C$32.04 million.
How can I contact Acasti Pharma?
Acasti Pharma's mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6872262.
MarketBeat Community Rating for Acasti Pharma (ACST)MarketBeat's community ratings are surveys of what our community members think about Acasti Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Acasti Pharma (CVE:ACST) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Acasti Pharma (CVE:ACST)
No earnings announcements for this company have been tracked by MarketBeat.com
Acasti Pharma (CVE:ACST) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Acasti Pharma (CVE:ACST)
No dividend announcements for this company have been tracked by MarketBeat.com
Acasti Pharma (CVE ACST) Insider Trading and Institutional Ownership History
Acasti Pharma (CVE ACST) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Acasti Pharma (CVE ACST) News Headlines
Acasti Pharma (CVE:ACST) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Acasti Pharma (CVE ACST) Stock Chart for Saturday, January, 20, 2018